1. Home
  2. CLSD vs AUST Comparison

CLSD vs AUST Comparison

Compare CLSD & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • AUST
  • Stock Information
  • Founded
  • CLSD 2011
  • AUST 2020
  • Country
  • CLSD United States
  • AUST Canada
  • Employees
  • CLSD N/A
  • AUST N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • AUST
  • Sector
  • CLSD Health Care
  • AUST
  • Exchange
  • CLSD Nasdaq
  • AUST Nasdaq
  • Market Cap
  • CLSD 20.4M
  • AUST 22.2M
  • IPO Year
  • CLSD 2016
  • AUST 2022
  • Fundamental
  • Price
  • CLSD $2.75
  • AUST $1.46
  • Analyst Decision
  • CLSD Hold
  • AUST
  • Analyst Count
  • CLSD 4
  • AUST 0
  • Target Price
  • CLSD $75.00
  • AUST N/A
  • AVG Volume (30 Days)
  • CLSD 42.9K
  • AUST 93.7K
  • Earning Date
  • CLSD 11-14-2025
  • AUST 11-06-2025
  • Dividend Yield
  • CLSD N/A
  • AUST N/A
  • EPS Growth
  • CLSD N/A
  • AUST N/A
  • EPS
  • CLSD N/A
  • AUST N/A
  • Revenue
  • CLSD $3,329,000.00
  • AUST N/A
  • Revenue This Year
  • CLSD $98.20
  • AUST N/A
  • Revenue Next Year
  • CLSD $213.77
  • AUST N/A
  • P/E Ratio
  • CLSD N/A
  • AUST N/A
  • Revenue Growth
  • CLSD N/A
  • AUST N/A
  • 52 Week Low
  • CLSD $2.54
  • AUST $1.05
  • 52 Week High
  • CLSD $17.10
  • AUST $2.94
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 33.87
  • AUST 38.22
  • Support Level
  • CLSD $2.54
  • AUST $1.46
  • Resistance Level
  • CLSD $4.00
  • AUST $1.69
  • Average True Range (ATR)
  • CLSD 0.34
  • AUST 0.18
  • MACD
  • CLSD -0.16
  • AUST -0.01
  • Stochastic Oscillator
  • CLSD 10.47
  • AUST 12.48

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About AUST Austin Gold Corp.

Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).

Share on Social Networks: